Study Suggests Limited Efficacy of OTC Meds for Chronic Idiopathic Constipation
Results showed that the majority of patients expressed dissatisfaction with the effect of the OTC agent on constipation and CIC-specific abdominal symptoms.
Constipation And Bowel Cleansers
Sutab Tablets Now Available for Colonoscopy Prep
The product is administered as a split-dose regimen consisting of 2 doses.
Generic Version of Amitiza Now Available
The Company has begun shipping both the 8mcg and 24mcg capsules; the capsules are supplied in 60-count bottles.
FDA Approves Sulfate-Based Tablet Prep for Colonoscopy
Available as a sulfate-based tablet, Sutab provides an alternative to liquid-based colonoscopy preparations.
Pizensy Approved for Chronic Idiopathic Constipation
The FDA has approved Pizensy (lactitol; Sebela) for oral solution, an osmotic laxative, for the treatment of chronic idiopathic constipation (CIC) in adult patients.
Clenpiq Approved for Pediatric Use in Colonoscopy Prep
The prescribing information for Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid; Ferring) has been updated to include use in pediatric patients ≥9 years old for cleansing of the colon as a preparation for colonoscopy. Previously, the treatment had only been approved for adult use. Clenpiq is a combination of sodium picosulfate, a stimulant…
DocuSol Kids Available OTC for Children With General Constipation
DocuSol Kids has been made available by Alliance Labs for the over-the-counter (OTC) treatment of general constipation in children 2–12 years of age. Each DocuSol Kids mini-enema (5mL) contains a delivered dose of docusate sodium 100mg in a polyethylene glycol base. The soft flexible tip allows for easy rectal usage under adult supervision. According to…
Opioid-Induced Constipation Management Guidelines
Recommendations from the American Gastroenterological Association (AGA) for the medical management of opioid-induced constipation (OIC).
Motegrity Approved for Chronic Idiopathic Constipation in Adults
Shire announced that the Food and Drug Administration (FDA) has approved Motegrity (prucalopride) tablets for the treatment of adults with chronic idiopathic constipation (CIC).
FDA Panel Votes on Prucalopride for Chronic Idiopathic Constipation
The panel’s decision was made based on data from from five Phase 3 studies and one Phase 4 trial which evaluated the safety and efficacy of prucalopride in patients with chronic constipation.
